Showing results (61-70 of 468) with videos related to
Sort By:
Pageof 47
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatmentAxel Grothey, Daniel Sargent, Richard M Goldberg, et al.Annals of Surgical Oncology|March 3, 2015
Landscape of neoadjuvant therapy for breast cancerTufia C Haddad, Matthew P GoetzClinical Colorectal Cancer|June 23, 2004
Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancersKarin Jordan, Olaf Kellner, Thomas Kegel, et al.Nature Reviews. Clinical Oncology|September 4, 2013
Drug rechallenge and treatment beyond progression--implications for drug resistanceElizabeth A Kuczynski, Daniel J Sargent, Axel Grothey, et al.Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Optimizing the treatment sequence from second-line to third-line therapy in patients with metastatic colorectal cancerAxel Grothey, Tanios S Bekaii-Saab, Takayuki Yoshino, et al.Cancer Treatment Reviews|March 22, 2020
Evolving role of regorafenib for the treatment of advanced cancersAxel Grothey, Jean-Yves Blay, Nick Pavlakis, et al.The Journal of Clinical Investigation|December 21, 2013
The search for treatments to reduce chemotherapy-induced peripheral neuropathyDeirdre R Pachman, Charles L Loprinzi, Axel Grothey, et al.Clinical Colorectal Cancer|December 10, 2017
Leptomeningeal Carcinomatosis in Colorectal Cancer: The Mayo Clinic ExperienceGretchen Taylor, Nina Karlin, Thorvardur R Halfdanarson, et al.BMJ (Clinical Research Ed.)|May 30, 2023
Advances in systemic therapies for triple negative breast cancerRoberto A Leon-Ferre, Matthew P GoetzNature Reviews. Clinical Oncology|April 7, 2010
Biomarkers and surrogate end points--the challenge of statistical validationMarc Buyse, Daniel J Sargent, Axel Grothey, et al.Pageof 47